Assessing cardiac risk in Chronic Kidney Disease patients without acclaimed Cardiovascular Disease
DOI:
https://doi.org/10.46568/bios.v6i1-2.230Keywords:
Cardiovascular Disease, Hypertension, diabetes, chronic kidney diseaseAbstract
Background: Chronic Kidney Disease (CKD) is among the self-regulating threat directing to cardiovascular diseases (CVD). The threat to heart advances with the elevated intensity of kidney abnormality. Various insults like hypertension, hyperglycemia, hypercholesterolemia, and obesity accompanying the CKD causes premature and brisk development of CVD. But a timely preventive measure may deaccelerate pathogenic development from silent to established disease. Therefore, the research was aimed to assess the Cardiac risk ratio in these patients prior to onset.
Methodology: The cross- sectional plan was executed in the period of 2024-2025. 100 CKD patients meeting inclusion requirement were inquired for demographics, through systematized questionnaire and blood samples were collected for kidney function tests & lipid profile assays following consent. Subjects were divided in three groups and cardiac risk ratio was estimated. Data was statistically analyzed at p<0.05 level of significance.
Results: The risk of cardiac disease was reported the most (approx. 60%) in diabetes, 43% in hypertensives, 34% in CKD counterparts without comorbidities.
Conclusion: the findings concluded that company of comorbidities precipitates cardiovascular disease likelihood and timely precautions may defer its onset refining overall health status and plummeting hospital visits.
Keywords:
Cardiovascular Risk Ratio, Chronic Kidney Disease, Hypertension, Diabetes
References
1. Michel Jadoul, Mabel Aoun, Mannix Masimango Imani, The major global burden of chronic kidney disease, The Lancet Global Health, Volume 12, Issue 3, 2024, Pages e342-e343, ISSN 2214-109X, https://doi.org/10.1016/S2214-109X(24)00050-0.
Zoccali, C., Mark, P.B., Sarafidis, P. et al. Diagnosis of cardiovascular disease in patients with chronic kidney disease. Nat Rev Nephrol 19, 733–746, 2023 https://doi.org/10.1038/s41581-023-00747-4
Cozzolino M, Mangano M, Stucchi A, Ciceri P, Conte F, Galassi A. Cardiovascular disease in dialysis patients. Nephrol Dial Transplant. 2018; 33(suppl_3):iii28-iii34. doi:10.1093/ndt/gfy174
US Renal Data System 2024 Annual Data Report: Epidemiology of Kidney Disease in the United States Johansen, Kirsten L. et al. American Journal of Kidney Diseases, Volume 85, Issue 6, A8 - A11
Harold E. Bays, Pam R. Taub, Elizabeth Epstein, Erin D. Michos, Richard A. Ferraro, Alison L. Bailey, Heval M. Kelli, Keith C. Ferdinand, Melvin R. Echols, Howard Weintraub, John Bostrom, Heather M. Johnson, Kara K. Hoppe, Michael D. Shapiro, Charles A. German, Salim S. Virani, Aliza Hussain, Christie M. Ballantyne, Ali M. Agha, Peter P. Toth, Ten things to know about ten cardiovascular disease risk factors, American Journal of Preventive Cardiology, Volume 5, 2021, 100149, ISSN 2666-6677, https://doi.org/10.1016/j.ajpc.2021.100149.
Flora GD, Nayak MK. A Brief Review of Cardiovascular Diseases, Associated Risk Factors and Current Treatment Regimes. Curr Pharm Des. 2019; 25(38):4063-4084. doi:10.2174/1381612825666190925163827
Antonio De Pascalis, Alessandro Tomassetti, Daniele Vetrano, Edoardo Tringali, Luca Di Lullo, Marcello Napoli, Gaetano La Manna, Giuseppe Cianciolo; Hypertension in Cardiovascular and Kidney Disease: Recent Trends – Treating Two Diseases as One. Cardiorenal Med 14 May 2024; 14 (1): 581–587. https://doi.org/10.1159/000541876
Wissam Ahmed, Sharareh Vahabi, Azfar G. Zaman, Reducing cardiovascular risk in patients with type 2 diabetes mellitus, Medicine, Volume 50, Issue 11, 2022, Pages 691-695, ISSN 1357-3039, https://doi.org/10.1016/j.mpmed.2022.08.001.
Afshinnia, Farsad1; Pennathur, Subramaniam1,2. Lipids and Cardiovascular Risk with CKD. CJASN 15(1):p 5-7, January 2020. | DOI: 10.2215/CJN.13531119
Ceja-Galicia ZA, Aranda-Rivera AK, Amador-Martínez I, Aparicio-Trejo OE, Tapia E, Trujillo J, Ramírez V, Pedraza-Chaverri J. The Development of Dyslipidemia in Chronic Kidney Disease and Associated Cardiovascular Damage, and the Protective Effects of Curcuminoids. Foods. 2023; 12(5):921. https://doi.org/10.3390/foods12050921
Go AS, Tan TC, Chertow GM, et al. Primary Nephrotic Syndrome and Risks of ESKD, Cardiovascular Events, and Death: The Kaiser Permanente Nephrotic Syndrome Study. J Am Soc Nephrol. 2021;32 (9):2303-2314. doi:10.1681/ASN.2020111583
Stacey C. Regis, Daniel Del Castillo-Rix, Rosario Colombo, Patterns of coronary artery disease trends in patients with nephrotic syndrome: A national inpatient study, International Journal of Cardiology, Volume 410, 2024, 132200, ISSN 0167-5273, https://doi.org/10.1016/j.ijcard.2024.132200.
Heerspink, H, Neuen, B, Inker, L. Chronic Kidney Disease Progression in Heart Failure: What We Know, Don’t Know, and Where to Next ?∗ . J Am Coll Cardiol HF. 2024 May, 12 (5) 860–863.https://doi.org/10.1016/j.jchf.
Charlotte Andersson, Matthew Nayor, Connie W. Tsao, Daniel Levy, Ramachandran S. Vasan, Framingham Heart Study: JACC Focus Seminar, 1/8, Journal of the American College of Cardiology, Volume 77, Issue 21, 2021, Pages 2680-2692, ISSN 0735-1097,
Ziad A. Massy, Dick de Zeeuw, LDL cholesterol in CKD—to treat or not to treat?, Kidney International, Volume 84, Issue 3, 2013, Pages 451-456, ISSN 0085-2538, https://doi.org/10.1038/ki.2013.181.
Bodaghi AB, Ebadi E, Gholami MJ, Azizi R, Shariati A. A decreased level of high-density lipoprotein is a possible risk factor for type 2 diabetes mellitus: a review. Health Sci Rep. 2023; 6:e1779. doi:10.1002/hsr2.1779
Prima Wulandari, Associations Between Triglyceride-Glucose Index And Cardiovascular Diseases: An Insight From Three-Years Nationwide Datasets, American Journal of Preventive Cardiology, Volume 19, Supplement, 2024, 100842, ISSN 2666-6677, https://doi.org/10.1016/j.ajpc.2024.100842.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Dr Ghazala Yasmeen, Dr. Zaibun-Nisa
This work is licensed under a Creative Commons Attribution 4.0 International License.
